Advertisement
Basaglar Coupon - Basaglar five 3ml kwikpens of 100 units/ml carton

Basaglar (insulin glargine) is a long-acting type of insulin. It is the first biosimilar insulin used to control blood sugar levels in diabetes mellitus, including diabetes type 1 and diabetes type 2.

GoodRx has partnered with InsideRx and Boehringer Ingelheim to reduce the price for this prescription. Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Basaglad is covered by some Medicare and insurance plans.

Basaglar Coupon - Basaglar five 3ml kwikpens of 100 units/ml carton

Basaglar Latest News

Get the latest updates on this drug from the GoodRx medical team

Eli Lilly Offers New Program To Help With Insulin Affordability

Roni Shye - September 19, 2018

If you’re having trouble affording your insulin, you’re not alone. Research has shown that expenses for diabetes can reach well beyond $1,000 a monthleaving many who cannot afford this cost without care.

In response to the ever-climbing prices of insulin, manufacturer Eli Lilly created the Lilly Diabetes Solution Center, a helpline aimed at finding personalized solutions for uninsured and low-income individuals who need help paying for their insulin. See More

Insulin Prices Continue to Rise as Manufacturers Promise Cost Relief

Benita Lee - September 05, 2018

Despite outrage over the high cost of insulin, prices for popular insulin treatments have continued to climb in 2018, according to a GoodRx analysis of drug prices.

Though prices are not climbing as quickly as they did between 2002 and 2013—when the average cost of insulin therapy tripled—the average price of insulin has increased by 64% since January 2014. Since the beginning of 2017, when drug prices became a key part of White House agenda, insulin prices have increased by 9% on average. See More

How To Save on Insulin — With or Without Insurance Coverage

Dr. Sharon Orrange - August 21, 2018

Cutting down or rationing insulin has dire consequences for all type 1 as well as type 2 diabetics dependent on insulin. Working in a busy practice alongside an endocrinologist with predominantly type 1 diabetic patients, I’ve seen the team behind our doctors working hard to keep insulin affordable for patients. Here is what I’ve learned from the best.

Steps for insured patients

If you’re about to take insulin, choose one that’s preferred:

  1. Call your insurance first to find their preferred insulin products.
  2.  See More

FDA Approves New Long-Acting Insulin Toujeo Max SoloStar

Roni Shye - April 10, 2018

Long-acting insulins are only administered once or twice daily, and include drugs like Lantus, Toujeo, Basaglar, and Levemir. As of March 27th, we have a new one to add to the long-acting insulin family – Toujeo Max SoloStar.

What is Toujeo Max SoloStar indicated for?

Toujeo Max SoloStar is indicated to improve blood sugar control in adults with diabetes. It will be available in a 3 ml disposable prefilled SoloStar pen in the strength of 300 units/ml. See More

Why is Humalog Expensive? And How Can You Save?

Tori Marsh - January 17, 2018

Humalog (insulin lispro) is a fast-acting insulin used to treat diabetes type one and two. Doctors report low levels of adherence to insulins like Humalog because of its cost. Cash prices for Humalog average around $549 for five kwikpens, and there is no generic alternative for any insulin rbrand. Humalog generated billions of dollars in global sales for Eli Lilly in 2016.

Here is some information on Humalog, and how you can save. See More

Why is Lantus so Expensive? And How Can You Save?

Tori Marsh - December 22, 2017

One of the only ways to treat diabetes type 1 and 2 are through insulin injections, like Lantus (insulin glargine), that help to control blood sugar. Unfortunately, doctors consistently report low levels of adherence to insulins, Lantus included. The main reason? The cost.

Lantus is a prime example of an expensive insulinaveraging around $274 per month, it is unaffordable for many. But GoodRx is here to help.

Here is some information on Lantus, and how you can save

Why are insulins, and Lantus, so expensive?

The case of insulin prices is an interesting one. See More

Rapid-Acting Versus Long-Acting Insulin: What’s the Difference?

Roni Shye - November 21, 2017

For people who need to take insulin, there are a couple of different typeslong-acting, short-acting, rapid-acting, intermediate-acting, etc. That’s a lot of options!

One question I see most often is the difference between rapid-acting and long-acting insulins. So, let’s get into it.   

What is rapid-acting insulin?

Rapid-acting, or meal-time insulin, is a type of insulin that’s usually taken before, during, or after a meal to lower your blood sugar levels associated with meals. See More

FDA Approves Long-Acting Insulin Lusduna

Roni Shye - July 28, 2017

If you have type 2 diabetes, your doctor or health care provider has most likely prescribed you a long acting insulin like Lantus (insulin glargine), Toujeo (insulin glargine), or Basaglar (insulin glargine). These type of insulins work to control your blood sugar between meals and when you’re sleeping. They can be injected once or twice a day to give you around-the-clock blood sugar control.

Lusduna Nexvue (insulin glargine) is the newest brand of long-acting insulin to gain FDA approval. See More

This Class of Drugs Causes Almost 100,000 Annual Emergency Visits

Dr. Sharon Orrange - June 07, 2016

Insulin: legal, widely used, and transforms lives. But there are risks—soon you’ll see why we try to spare our type II diabetics from having to start insulin. Using oral medications to their maximum dose and incorporating diet and lifestyle changes is the way to go before resorting to insulin.

Of course, tight blood sugar control is the goal for reducing diabetes related complications (kidney disease, eye disease, neuropathy) but insulin remains one of the most challenging aspects of diabetes management given the risks. See More

New Insulin Basaglar in Pharmacies This Year

Roni Shye - February 17, 2016

Basaglar (insulin glargine) is the newest brand of long-acting insulin to hit the market. It shares its active ingredient (insulin glargine) with Lantus, but is not a generic equivalent and the two can’t be substituted for each other.

Long-acting insulin like Basaglar (also sometimes referred to as basal insulin) are used to keep blood glucose levels stable throughout the day.

There are now four long-acting insulins approved by the FDA: Lantus, Levemir (insulin detemir), Toujeo (insulin glargine recombinant), Tresiba (insulin degludec), and BasaglarSee More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy